Details of the Drug Reposition
General Information of This Drug (ID: DMLDQFV)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | SEP-225289; SEP-289; Triple reuptake inhibitors (depression), Sepracor | |||||
| Drug Type | Small molecular drug | |||||
| Structure |  | |||||
| 3D MOL | 2D MOL | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Approved Indication(s) | 
 | ||||||||||||||||||||||||||||||
| 2 Phase 3 Indication(s) | 
 | ||||||||||||||||||||||||||||||
References
